BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7795572)

  • 1. Anxiety and addiction: a clinical perspective on comorbidity.
    DuPont RL
    Bull Menninger Clin; 1995; 59(2 Suppl A):A53-72. PubMed ID: 7795572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety and substance use: layers of complexity.
    Castle DJ
    Expert Rev Neurother; 2008 Mar; 8(3):493-501. PubMed ID: 18345977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does one manage a patient with an anxiety disorder who has been self-medicating with psychotropic drugs?
    Wilson A
    J Psychiatry Neurosci; 1999 Nov; 24(5):483. PubMed ID: 11499430
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of alcohol and drugs to self-medicate anxiety disorders in a nationally representative sample.
    Bolton J; Cox B; Clara I; Sareen J
    J Nerv Ment Dis; 2006 Nov; 194(11):818-25. PubMed ID: 17102705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and treating comorbid anxiety disorders in substance users: review and future directions.
    Wolitzky-Taylor K; Operskalski JT; Ries R; Craske MG; Roy-Byrne P
    J Addict Med; 2011 Dec; 5(4):233-47. PubMed ID: 22042216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-medication of anxiety disorders with alcohol and drugs: Results from a nationally representative sample.
    Robinson J; Sareen J; Cox BJ; Bolton J
    J Anxiety Disord; 2009 Jan; 23(1):38-45. PubMed ID: 18571370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety and psychoactive substance use disorder comorbidity in anorexia nervosa or depression.
    Jordan J; Joyce PR; Carter FA; Horn J; McIntosh VV; Luty SE; McKenzie JM; Mulder RT; Bulik CM
    Int J Eat Disord; 2003 Sep; 34(2):211-9. PubMed ID: 12898557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients].
    Lambert M; Haasen C; Mass R; Krausz M
    Psychiatr Prax; 1997 Jul; 24(4):185-9. PubMed ID: 9340658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of psychotropic substance abuse and addiction in the treatment of psychosomatic rehabilitation patients].
    Wiehn T; Domma J; Vollmer HC
    Rehabilitation (Stuttg); 2008 Jun; 47(3):158-63. PubMed ID: 18553246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual diagnosis in Spain.
    Gual A
    Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual diagnosis.
    Turnbull JM; Roszell DK
    Prim Care; 1993 Mar; 20(1):181-90. PubMed ID: 8464939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperament, substance use and psychopathology in a prisoner population: implications for treatment.
    Allnutt S; Wedgwood L; Wilhelm K; Butler T
    Aust N Z J Psychiatry; 2008 Nov; 42(11):969-75. PubMed ID: 18941962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder.
    Bauer MS; Altshuler L; Evans DR; Beresford T; Williford WO; Hauger R;
    J Affect Disord; 2005 Apr; 85(3):301-15. PubMed ID: 15780700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How should drugs for anxiety be prescribed?].
    Baylé FJ
    Encephale; 1998; 24(3):272-9. PubMed ID: 9696923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician addiction and impairment--current thinking: a review.
    Centrella M
    J Addict Dis; 1994; 13(1):91-105. PubMed ID: 8018742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comorbidity of anxiety and depression: epidemiologic perspectives].
    Lépine JP
    Encephale; 1994 Dec; 20 Spec No 4():683-92. PubMed ID: 7895636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comorbid psychiatric symptoms in pathological gamblers: anxiety, depression and substance abuse].
    Dannon P; Sason M; Shalgi B; Tusan L; Sapir Y; Kotler M
    Harefuah; 2004 Sep; 143(9):643-6, 695. PubMed ID: 15521678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.